ARVIND REMEDIES LIMITED
				UNAUDITED FINANCIAL RESULTS
				FOR THE QUARTER ENDED JUNE 30, 2007
							(Rupees in Lakhs.)
				Particulars	Three months ended 30.06.2007	Corresponding Three months ended 30.06.2006	Year ended 31.3.2007
					Unaudited	Unaudited	Audited
				Gross Sales	4,595.80	4,391.95	17,972.93
				Less: Excise Duty	(548.58)	(474.08)	(2,314.43)
				Net Sales	4,047.22	3,917.87	15,658.50
				Other Income	2.58	2.78	21.58
				Total Income	4,049.80	3,920.65	15,680.08
				Total expenditure :
				a)  (Increase) / Decrease in Stock	(255.62)	153.39	(300.68)
				b)  Materials Consumed	3,587.91	3,121.73	13,647.63
				c)  Staff Cost	92.52	78.26	340.42
				d)  Other expenditure	130.54	112.56	618.13
				Total (a) to (d)	3,555.35	3,465.94	14,305.50
				Gross Profit before Interest & Depreciation	494.45	454.71	1,374.58
				Interest	163.37	134.25	655.18
				Depreciation	43.64	41.21	170.12
				Profit before Tax	287.44	279.25	549.28
				Provision for Taxation
				Income Tax (Including Fringe Benefit Tax)	26.73	20.00	85.86
				Earlier years	-	-	(31.48)
				Deferred Tax	(12.72)	(10.03)	56.13
				Wealth Tax	-	-	0.29
				Profit / (Loss) after Tax	273.43	269.28	438.48
				Paid-up Equity Share Capital	2600.50	2600.50	2600.50
				(face value Re. 1/- per Share)
				Reserves excluding Revaluation Reserve	-	-	1,521.31
				Basic and Diluted Earnings Per Share (Rs.)	0.11	0.10	0.17
				Aggregate of Non-Promoter Shareholding
				Number of shares	194205340	194205340	194205340
				Percentage of Shareholding	74.68%	74.68%	74.68%
				Note :
				1. The Company operates only in one business segment namely  formulations.
				2. Previous period's figures have been regrouped / rearranged  wherever necessary to confirm to the current periods classification.
				3. The revised Accounting Standard 15 "Employee Benefits" issued by the Institute of Chartered Accountants of India has become
				applicable to the Company with effect from April 1, 2007.  The impact of such revision, which is not likely to be material, will be
				considered at the year end.
				4. The above results were reviewed by the audit committee and taken on record at the meeting of the Board of Directors
				held on August 30, 2007
				5. During the quarter 7 investor complaints were received and disposed off.  There were no investor complaints pending for the
				redressal as at the commencement and end of the quarter.
				6. The above results for the quarter ended June 30, 2007, have been subjected to a Limited Review by the statutory auditors as per
				the listing agreement with the stock exchanges.
				Chennai - 600 084		For ARVIND REMEDIES LTD.
				Date: August 30, 2007
						Dr. B Arvind Shah
						CEO and Managing Director